Large-scale health insurance study showed that antibiotic use in infancy was associated with an increase in atopic

Tetsuya Tsuchida1, Satomi Yoshida1, Masato Takeuchi1

  • 1Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan.

Insights

Infant antibiotic exposure showed an initial link to atopic dermatitis (AD), but this association vanished in sibling-matched analyses, suggesting antibiotics may not be a critical factor for AD development.

Area of Science:

  • Pediatrics
  • Dermatology
  • Pharmacology

Background:

  • Infant antibiotic exposure is a growing concern.
  • The link between early antibiotic use and atopic dermatitis (AD) requires further investigation.

Purpose of the Study:

  • To examine the association between antibiotic prescription in infancy and the subsequent development of atopic dermatitis (AD).

Main Methods:

  • Retrospective analysis of a Japanese health insurance claims database (2005-2014).
  • Involved over 85,000 infants, comparing antibiotic exposure in the first 12 months of life with subsequent AD diagnosis.
  • Utilized multivariable Cox regression and sibling-matched analyses to control for confounders.

Main Results:

  • Initial analysis indicated a higher likelihood of AD in infants prescribed antibiotics.
  • However, a sibling-matched analysis found no significant association between infant antibiotic use and AD.
  • Identified macrolides, aminoglycosides, food allergies, and H1 antagonists as other risk factors for AD.

Conclusions:

  • While an initial association was observed, infant antibiotic use may not be a critical factor in the development of atopic dermatitis.
  • Prescribing decisions for infant antibiotics should consider potential associations, but causality is not established by this study.
Abstract